APOBEC3B Improves Response to PD-1 Blockade Through DSBs–ATR–CHK1 Pathway
Hong Yang(Southern Medical University), Wei Wang(Capital Medical University), Ziyi Luo(Southern Medical University), Shuai Chu(Nanfang Hospital), Qin Zeng(Nanfang Hospital), Wei Guo(Fudan University), Yueyun Ma(Air Force General Hospital PLA), Yanxia Wang(Inner Mongolia Agricultural University), Tongxin Liu(Southern Medical University), Shiyu Chen(Southern Medical University), Xiaomei Zhou(Huazhong University of Science and Technology), Rong Wang(Jiangnan University), Bin Xie(Swedish Medical Center)
Cited by 0
Related Papers
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
|Science Immunology|2020|151
Accelerated Generation of Selfed Pure Line Plants for Gene Identification and Crop Breeding
|Frontiers in Plant Science|2017|129
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
|Pharmacological Reviews|2024|127